rs2066470

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_005957.5(MTHFR):​c.117C>T​(p.Pro39Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.102 in 1,613,948 control chromosomes in the GnomAD database, including 8,874 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.093 ( 708 hom., cov: 32)
Exomes 𝑓: 0.10 ( 8166 hom. )

Consequence

MTHFR
NM_005957.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -7.56

Publications

61 publications found
Variant links:
Genes affected
MTHFR (HGNC:7436): (methylenetetrahydrofolate reductase) The protein encoded by this gene catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a co-substrate for homocysteine remethylation to methionine. Genetic variation in this gene influences susceptibility to occlusive vascular disease, neural tube defects, colon cancer and acute leukemia, and mutations in this gene are associated with methylenetetrahydrofolate reductase deficiency.[provided by RefSeq, Oct 2009]
MTHFR Gene-Disease associations (from GenCC):
  • homocystinuria due to methylene tetrahydrofolate reductase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 1-11803000-G-A is Benign according to our data. Variant chr1-11803000-G-A is described in ClinVar as Benign. ClinVar VariationId is 292246.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-7.56 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.147 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MTHFRNM_005957.5 linkc.117C>T p.Pro39Pro synonymous_variant Exon 2 of 12 ENST00000376590.9 NP_005948.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MTHFRENST00000376590.9 linkc.117C>T p.Pro39Pro synonymous_variant Exon 2 of 12 1 NM_005957.5 ENSP00000365775.3

Frequencies

GnomAD3 genomes
AF:
0.0930
AC:
14147
AN:
152076
Hom.:
711
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0779
Gnomad AMI
AF:
0.0482
Gnomad AMR
AF:
0.0650
Gnomad ASJ
AF:
0.0317
Gnomad EAS
AF:
0.124
Gnomad SAS
AF:
0.156
Gnomad FIN
AF:
0.126
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.101
Gnomad OTH
AF:
0.0766
GnomAD2 exomes
AF:
0.0976
AC:
24504
AN:
251096
AF XY:
0.0997
show subpopulations
Gnomad AFR exome
AF:
0.0752
Gnomad AMR exome
AF:
0.0622
Gnomad ASJ exome
AF:
0.0339
Gnomad EAS exome
AF:
0.122
Gnomad FIN exome
AF:
0.116
Gnomad NFE exome
AF:
0.0977
Gnomad OTH exome
AF:
0.0869
GnomAD4 exome
AF:
0.103
AC:
151010
AN:
1461754
Hom.:
8166
Cov.:
32
AF XY:
0.104
AC XY:
75660
AN XY:
727160
show subpopulations
African (AFR)
AF:
0.0781
AC:
2616
AN:
33480
American (AMR)
AF:
0.0623
AC:
2785
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.0343
AC:
896
AN:
26128
East Asian (EAS)
AF:
0.109
AC:
4324
AN:
39700
South Asian (SAS)
AF:
0.143
AC:
12322
AN:
86232
European-Finnish (FIN)
AF:
0.112
AC:
5982
AN:
53410
Middle Eastern (MID)
AF:
0.0432
AC:
249
AN:
5768
European-Non Finnish (NFE)
AF:
0.104
AC:
115567
AN:
1111928
Other (OTH)
AF:
0.104
AC:
6269
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
9029
18059
27088
36118
45147
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4318
8636
12954
17272
21590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0929
AC:
14144
AN:
152194
Hom.:
708
Cov.:
32
AF XY:
0.0944
AC XY:
7022
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.0777
AC:
3228
AN:
41528
American (AMR)
AF:
0.0646
AC:
988
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0317
AC:
110
AN:
3472
East Asian (EAS)
AF:
0.124
AC:
641
AN:
5174
South Asian (SAS)
AF:
0.156
AC:
753
AN:
4818
European-Finnish (FIN)
AF:
0.126
AC:
1338
AN:
10586
Middle Eastern (MID)
AF:
0.0476
AC:
14
AN:
294
European-Non Finnish (NFE)
AF:
0.101
AC:
6866
AN:
68012
Other (OTH)
AF:
0.0768
AC:
162
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
644
1289
1933
2578
3222
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
172
344
516
688
860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0931
Hom.:
1382
Bravo
AF:
0.0859
Asia WGS
AF:
0.127
AC:
440
AN:
3478
EpiCase
AF:
0.0915
EpiControl
AF:
0.0854

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 25, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Homocystinuria due to methylene tetrahydrofolate reductase deficiency Benign:2
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
0.20
DANN
Benign
0.90
PhyloP100
-7.6
PromoterAI
0.0018
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2066470; hg19: chr1-11863057; COSMIC: COSV56738175; COSMIC: COSV56738175; API